,
inhibitors of DNA methyltransferase*, histone deacetylase* and histone methyltransferase* are used
Coignard, J.,
Lush, M.,
Beesley, J.,
O’Mara, T.A.,
Dennis, J,
Tyrer, J.P.,
Barnes, D.R.,
McGuffog, L.,
Leslie, G.,
Bolla, M.K.,
Adank, M.A.,
Kiiski, J.I.,
Nevanlinna, H.,
team of authors (2021) may exist but studies of mutation carriers have so far been underpowered. We conduct a
novel case
Guan, XX,
Zhang, YW,
Gareev, I,
Beylerli, O,
Li, XY,
Lu, GT,
Lv, L,
Hai, X (2021) completely reversed the inflammatory response. Knockdown of miR-499a by its specific
inhibitor in healthy
Ivanova, E.,
Asadullina, D.,
Rakhimov, R.,
Izmailov, A.,
Izmailov, Al.,
Gilyazova, G.,
Galimov, Sh.,
Pavlov, V.,
Khusnutdinova, E.,
Gilyazova, I. (2022) related toxicity. Immune-related adverse events (irAEs) are a major cause of immune checkpoint
inhibitors